N1087

· Eurofarma Laboratorios S.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for N1087, covering 2026-01-09 to 2026-01-09. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of N1087 in Participants With Female Pattern Hair Loss (MINORA-WOMEN) [Phase 3]

See pricing